Moscow State University

Introduction

Moscow State University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Lomonosov Moscow State University (MSU) is Russia's premier research university and one of the oldest and most prestigious institutions of higher education in Eastern Europe. Founded in 1755 by Mikhail Lomonosov, the university has established itself as a global center for neuroscience research, particularly in the field of neurodegenerative diseases. The university's Department of Brain and Cognitive Sciences and affiliated research institutes conduct world-class research on Alzheimer's disease, Parkinson's disease, and other neurological disorders. [@faculty]

Overview

Introduction

Moscow State University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Lomonosov Moscow State University (MSU) is Russia's premier research university and one of the oldest and most prestigious institutions of higher education in Eastern Europe. Founded in 1755 by Mikhail Lomonosov, the university has established itself as a global center for neuroscience research, particularly in the field of neurodegenerative diseases. The university's Department of Brain and Cognitive Sciences and affiliated research institutes conduct world-class research on Alzheimer's disease, Parkinson's disease, and other neurological disorders. [@faculty]

Overview

| | |
|---|---|
| Full Name | Lomonosov Moscow State University |
| Location | Moscow, Russia |
| Type | Public Research University |
| Founded | 1755 |
| Website | https://www.msu.ru |

Moscow State University is consistently ranked among the top 100 universities globally and is the highest-ranked Russian institution in international rankings. The university comprises 39 faculties and more than 380 departments, with particular strength in basic and applied biomedical sciences.

Neuroscience Research Programs

Neurobiology of Disease

Alzheimer's Disease Research

• Amyloid Biology: Studies on [Aβ](/proteins/amyloid-beta) metabolism and aggregation mechanisms
• [Tau](/proteins/tau) Pathology: Phosphorylation and propagation of [tau](/proteins/tau) pathology
• Neuroinflammation: Role of [microglia](/entities/microglia) and neuroinflammation in AD progression
• Translational Research: Development of diagnostic and therapeutic approaches

Parkinson's Disease Research

• [Alpha-Synuclein](/proteins/alpha-synuclein): Molecular mechanisms of [α-synuclein](/proteins/alpha-synuclein) aggregation
• Dopaminergic [Neurons](/entities/neurons): Vulnerability mechanisms in substantia nigra pars compacta
• Mitochondrial Dysfunction: Role of mitochondrial defects in PD pathogenesis
• Neuroprotection: Identification of neuroprotective compounds

Other Neurodegenerative Conditions

• Amyotrophic Lateral Sclerosis (ALS): Genetic and cellular mechanisms
• Huntington's Disease: Transcriptional dysregulation studies
• Prion Diseases: Protein misfolding and propagation mechanisms
• Multiple Sclerosis: Autoimmune mechanisms and demyelination

Research Institutes and Centers

Institute of Higher Nervous Activity

• Neurophysiology of learning and memory
• Cortical plasticity studies
• Cognitive neuroscience
• Behavioral neuroscience

Biological Faculty - Department of Neurobiology

• Molecular neuroscience
• Developmental neurobiology
• Neurochemistry
• Neuropharmacology

Faculty of Fundamental Medicine

• Clinical neuroscience
• Neuropathology
• Neuroimaging
• Translational neurology

Key Research Facilities

Center for Cognitive Sciences

• Advanced neuroimaging (MRI, PET)
• Electrophysiology laboratory
• Cognitive testing suite
• Brain tissue bank

Laboratory of Molecular Neurobiology

• Protein biochemistry
• Cell culture facilities
• Animal models of neurodegeneration
• Gene editing capabilities

Neuroinformatics Center

• Bioinformatic analysis pipelines
• Machine learning for neuroimaging
• Database development
• Computational neuroscience modeling

Notable Contributions

Russian Brain Project

The Russian Brain Project (also known as BrainRussia or Национальная технологическая инициатива) is Russia's flagship neuroscience research initiative, with MSU serving as a leading institutional partner[@petrov2018]. This national program aims to advance understanding of brain function and develop treatments for neurological disorders.

The project encompasses several major research directions:

• Neural Circuit Mapping: Comprehensive mapping of neural networks in both normal and diseased states
• Neurotechnology Development: Brain-computer interfaces and neural prosthetics
• Computational Modeling: Large-scale simulations of neural systems
• Clinical Translation: Development of diagnostics and therapeutics for brain disorders

Alzheimer's Disease Research

MSU has established comprehensive programs in Alzheimer's disease research spanning basic science to clinical translation[@popov2019]:

Amyloid Biology
Research on amyloid-beta (Aβ) metabolism focuses on:

• APP processing and amyloid precursor protein biology
• Aβ aggregation mechanisms and toxic species identification
• Amyloid seeding and template-driven pathology spread
• Therapeutic targeting of amyloid pathways

• Kinase and phosphatase involvement in tau phosphorylation
• Tau propagation between neurons and brain regions
• Tau oligomer formation and toxicity mechanisms
• Tau-based diagnostic biomarker development

• Microglial activation states in AD progression
• Cytokine and chemokine profiling in patient samples
• Neuroinflammation as a therapeutic target
• Blood-brain barrier dysfunction in AD

Parkinson's Disease Research

MSU researchers have made significant contributions to understanding Parkinson's disease pathogenesis[@sokolov2017]:

Alpha-Synuclein Biology
The alpha-synuclein research program includes[@volkov2021]:

• Structural studies of α-synuclein aggregation
• Mechanisms of Lewy body formation
• Cell-to-cell transmission of pathological species
• Strain diversity and its clinical implications

• Mitochondrial dysfunction in PD models
• Oxidative stress mechanisms
• Calcium handling abnormalities
• Neurotrophic factor signaling

• Complex I deficiency in PD patients
• PINK1/Parkin mitophagy pathway
• Mitochondria-targeted therapeutics
• Metabolic reprogramming in neurodegeneration

Other Neurodegenerative Conditions

MSU conducts research across a broad spectrum of neurodegenerative diseases:

Amyotrophic Lateral Sclerosis (ALS)

• TDP-43 proteinopathy mechanisms
• SOD1 and C9orf72 genetics
• Motor neuron vulnerability
• Therapeutic screening platforms

• HTT gene and protein biology
• Transcriptional dysregulation
• Synaptic dysfunction
• Therapeutic interventions

• Prion protein misfolding mechanisms
• Strain typing and characterization
• Therapeutic approaches
• Diagnostic biomarker development

• Autoimmune mechanisms
• Demyelination and remyelination
• Neuroprotective strategies

History and Development

Foundation and Evolution

Moscow State University was founded in 1755 by Mikhail Lomonosov, a polymath scientist whose legacy continues to inspire the institution's commitment to excellence in research and education. The university's evolution into a major neuroscience center began in the mid-20th century with the establishment of the Institute of Higher Nervous Activity and the development of strong physiology and biology programs.

The post-Soviet period brought significant changes to Russian science, including:

• Restructuring of research funding systems
• Integration into international research networks
• Development of new research methodologies
• Expansion of international collaborations

Neuroscience at MSU: Key Milestones

| Year | Development |
|------|-------------|
| 1950s | Institute of Higher Nervous Activity established |
| 1970s | Department of Neurobiology created |
| 1990s | Center for Cognitive Sciences founded |
| 2000s | Faculty of Fundamental Medicine launched |
| 2010s | Russian Brain Project initiated |
| 2020s | International collaborations expanded |

Research Infrastructure

Core Facilities

MSU maintains state-of-the-art research facilities supporting neurodegeneration research[@beketov2018]:

Neuroimaging Center

• 3T and 7T MRI scanners
• PET/CT imaging capabilities
• Advanced neuroimaging protocols
• Multi-modal imaging integration

• Next-generation sequencing
• CRISPR gene editing
• Protein expression and purification
• Cell culture facilities

• Transgenic mouse models
• Behavioral testing suites
• Surgical capabilities
• Veterinary support

• High-performance computing
• Machine learning pipelines
• Database development
• Computational modeling

Brain Tissue Bank

The MSU brain tissue bank provides researchers with access to:

• Post-mortem brain samples from neurodegenerative disease patients
• Age-matched controls
• Associated clinical and pathological data
• Histological sections and frozen tissue

International Collaborations

Global Research Networks

MSU maintains active collaborations with leading international institutions:

European Partnerships

• Human Brain Project (EU Flagship)
• Horizon Europe research programs
• European Neuroscience Society
• Bilateral agreements with EU universities

• NIH-funded research programs
• Alzheimer's Association partnerships
• University exchange programs
• Joint publication projects

• Chinese Academy of Sciences
• Japanese neuroscience institutions
• Korean university partnerships

Joint Publications and Projects

MSU researchers contribute to numerous international collaborative publications, with research appearing in leading journals including Nature Neuroscience, Brain, Acta Neuropathologica, and Journal of Neuroscience[@ivanov2020].

Training and Education

Graduate Programs

MSU offers comprehensive training in neuroscience through[@orlov2017]:

Doctoral Programs (PhD)

• Neuroscience (3-4 years)
• Molecular and Cell Biology
• Biophysics
• Computational Neuroscience

• Cognitive Neuroscience
• Neurobiology
• Biomedical Engineering
• Data Science for Neuroscience

Postdoctoral Training

The university provides postdoctoral positions through:

• Individual fellowships
• Grant-funded positions
• Industry partnerships
• Clinical research training

Future Directions

Emerging Research Priorities

MSU is focusing on several cutting-edge research areas:

Strategic Initiatives

• Expand international research collaborations
• Enhance translational research capabilities
• Develop novel therapeutic approaches
• Strengthen clinical research infrastructure

Cross-References

Related Content

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary research focus
• [Parkinson's Disease](/diseases/parkinsons-disease) — Key research area
• [Russian Academy of Sciences](/institutions/russian-academy-of-sciences) — Partner institution
• [Neurodegeneration](/diseases/neurodegeneration) — Disease area
• [Mitochondria](/mechanisms/mitochondrial-dysfunction-pathway) — Research mechanism
• [Neuroinflammation](/mechanisms/neuroinflammation) — AD research focus
• [Alpha-Synuclein](/proteins/alpha-synuclein) — PD protein
• [Tau Protein](/proteins/tau) — AD protein
• [Amyloid Beta](/proteins/amyloid-beta) — AD protein

Related Institutions

• [Russian Academy of Sciences](/institutions/russian-academy-of-sciences)
• [Institute of Higher Nervous Activity](/institutions/russian-academy-of-sciences)
• [Human Brain Project](/institutions/human-brain-project)

References